Harsh Mulik’s Personalized Nudging Engine is Transforming Chronic Disease Treatment by Merging Behavioral Science with Advanced AI When Harsh Mulik, founder and CEO of HumLife360, took the stage at 1StartupWorld, […]
Type 2 Diabetes
Trending topics and news from the Type 2 Diabetes category
Back to news homeReduced risk of CV morbidity and mortality demonstrated in FIGARO-DKD study
At this year’s European Society of Cardiology (ESC) Congress, positive results were presented from Bayer’s FIGARO-DKD Phase III trial of Kerendia (finerenone), providing insight into the drug’s ability to reduce […]